China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- 2,000-year-old steel acupuncture needles unearthed in Jiangxi
- New carbon neutrality initiative launched in Beijing
- Three killed in downtown Guangzhou traffic accident
- How does the eight-point code profoundly change China?
- Xizang's first guide dog helps his owner break barriers
- AI revives 80 war veterans at memorial hall in Taiyuan
